SCHEMBL19913202

SCHEMBL19913202

N#Cc1ccc2c3ccccc3n(-c3cc(C#N)c(-c4ccncc4)cc3-n3c4ccccc4c4ccc(C#N)cc43)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
FLT3 P36888 3/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
SQOR Q9Y6N5 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
PKN1 Q16512 1/20 0.36
PKN2 Q16513 1/20 0.36
METAP2 P50579 1/20 0.36
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CDC7 O00311 1/20 0.34
LRRK2 Q5S007 3/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909045 0.94 PKN1 (0.39) CYP19A1CYP11B1CYP11B2FLT3PKN1
SCHEMBL19909469 0.93 CYP19A1 (0.38) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL19913203 0.93 CYP19A1 (0.38) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL19909005 0.92 STS (0.38) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL20923187 0.92 SQOR (0.39) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL19909025 0.92 FLT3 (0.39) CYP19A1CYP11B1CYP11B2FLT3SQOR
SCHEMBL20923078 0.92 CYP19A1 (0.39) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL20923081 0.91 CYP11B1 (0.36) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL20923820 0.91 CYP11B1 (0.37) CYP19A1CYP11B1CYP11B2FLT3ABCG2
SCHEMBL19909028 0.90 CYP1A2 (0.40) FLT3ABCG2SQORHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CYP19A1 2142/4885CYP11B1 610/4885CYP11B2 402/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 CYP19A1 3879/4885CYP11B1 1400/4885CYP11B2 965/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CYP19A1 2142/4885CYP11B1 610/4885CYP11B2 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.